Post Operative Sore Throat and Dexamethasone
NCT01052038
Completed
Sore throat is a common postoperative complaint that can lead to morbidity and patient dissatisfaction . The incidence of sore throat has been reported to be between 6% and 90% even under optimal intubating conditions. There are several factors that have been shown to contribute to postoperative sore throat such as patient related factors, type of anesthesia and type of surgery. Corticosteroids are also commonly used in the perioperative period to potentiate analgesics and as antiemetics. The p... Read More
Gender:
FEMALE
Ages:
Between 18 years and 64 years
Trial Updated:
04/05/2012
Locations: Northwesten University, Chicago, Illinois
Conditions: Sore Throat, Pain
Register for Updates
Expanded Access Program:Lenalidomide With or Without Dexamethasone In Previously Treated Subjects With Multiple Myeloma
NCT00179647
Completed
Subjects who qualify for participation will receive lenalidomide with or without dexamethasone in 4 week cycles until disease progression is documented or lenalidomide becomes commercially available for the indication of multiple myeloma.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
03/10/2010
Locations: Northwestern University Med CtrDivision of Hem/Onc, Chicago, Illinois +1 locations
Conditions: Multiple Myeloma
Register for Updates
A Study to Evaluate Lenalidomide Combined With Dexamethasone in Relapsed or Refractory Diffuse Large B-Cell Lymphoma
NCT00474188
Terminated
To evaluate the safety and efficacy of lenalidomide (Revlimid ®) in combination with dexamethasone in subjects with relapsed or refractory diffuse large B-cell lymphoma.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
08/27/2009
Locations: Cancer Care & Hematology Specialists of Chicagoland, Arlington Heights, Illinois +2 locations
Conditions: Diffuse Large B-cell Lymphoma
Register for Updates